F. Pignatti, M. Van-den-bent, D. Curran, C. Debruyne, R. Sylvester et al., Prognostic Factors for Survival in Adult Patients With Cerebral Low-Grade Glioma, Journal of Clinical Oncology, vol.20, issue.8, pp.2076-2084, 2002.
DOI : 10.1200/JCO.2002.08.121

N. Pouratian and D. Schiff, Management of Low-Grade Glioma, Current Neurology and Neuroscience Reports, vol.80, issue.Suppl 7, pp.224-255, 2010.
DOI : 10.1007/s11910-010-0105-7

J. Grier and T. Batchelor, Low-Grade Gliomas in Adults. The Oncologist, pp.681-693, 2006.

J. Smith, E. Chang, K. Lamborn, S. Chang, M. Prados et al., Role of Extent of Resection in the Long-Term Outcome of Low-Grade Hemispheric Gliomas, Journal of Clinical Oncology, vol.26, issue.8, pp.1338-1345, 2008.
DOI : 10.1200/JCO.2007.13.9337

A. Jakola, K. Myrmel, R. Kloster, S. Torp, S. Lindal et al., Comparison of a Strategy Favoring Early Surgical Resection vs a Strategy Favoring Watchful Waiting in Low-Grade Gliomas, JAMA, vol.308, issue.18, pp.1881-1888, 2012.
DOI : 10.1001/jama.2012.12807

J. Ruiz and G. Lesser, Low-Grade Gliomas, Current Treatment Options in Oncology, vol.346, issue.3-4, pp.231-242, 2009.
DOI : 10.1007/s11864-009-0096-2

D. García, K. Fulling, and J. Marks, The value of radiation therapy in addition to surgery for astrocytomas of the adult cerebrum, Cancer, vol.42, issue.5, pp.919-927, 1985.
DOI : 10.1002/1097-0142(19850301)55:5<919::AID-CNCR2820550502>3.0.CO;2-4

D. Molina, J. Pérez-beteta, B. Luque, E. Arregui, M. Calvo et al., Tumour heterogeneity in glioblastoma assessed by MRI texture analysis: a potential marker of survival, The British Journal of Radiology, vol.89, issue.1064, pp.20160242-27319577, 1064.
DOI : 10.1259/bjr.20160242

A. Martínez-gonzález, G. Calvo, J. Ayuso, I. Ochoa, L. Fernández et al., Hypoxia in Gliomas: Opening Therapeutical Opportunities Using a Mathematical-Based Approach, Advances in Experimental Medicine and Biology, vol.62, issue.7, pp.11-29, 2016.
DOI : 10.1093/imammb/dqv017

J. Murray, Mathematical Biology: I. An Introduction, 2007.

G. Powathil, M. Kohandel, S. Sivaloganathan, A. Oza, and M. Milosevic, Mathematical modeling of brain tumors: effects of radiotherapy and chemotherapy, Physics in Medicine and Biology, vol.52, issue.11, pp.3291-306, 2007.
DOI : 10.1088/0031-9155/52/11/023

L. Barazzuol, N. Burnet, J. R. Jones, B. Jefferies, S. Kirkby et al., A mathematical model of brain tumour response to radiotherapy and chemotherapy considering radiobiological aspects, Journal of Theoretical Biology, vol.262, issue.3, pp.553-565, 2010.
DOI : 10.1016/j.jtbi.2009.10.021

URL : https://hal.archives-ouvertes.fr/hal-00554654

E. Konokoglu, O. Clatz, P. Bondiau, H. Deligette, and N. Ayache, Extrapolating glioma invasion margin in brain magnetic resonance images: Suggesting new irradiation margins, Medical Image Analysis, vol.14, issue.2, pp.111-125, 2010.
DOI : 10.1016/j.media.2009.11.005

R. Rockne, K. Hendrickson, A. Lai, T. Cloughesy, E. Alvord et al., a mathematical modeling approach, Physics in Medicine and Biology, vol.55, issue.12, pp.3271-3285, 2010.
DOI : 10.1088/0031-9155/55/12/001

P. Bondiau, E. Konukoglu, O. Clatz, H. Delingette, M. Frenay et al., Biocomputing: Numerical simulation of glioblastoma growth and comparison with conventional irradiation margins, Physica Medica, vol.27, issue.2, pp.103-108, 2010.
DOI : 10.1016/j.ejmp.2010.05.002

K. Leder, Q. Laplant, D. Hambardzumyan, B. Ross, T. Chan et al., Mathematical Modeling of PDGF-Driven Glioblastoma Reveals Optimized Radiation Dosing Schedules, Cell, vol.156, issue.3, pp.603-616, 2014.
DOI : 10.1016/j.cell.2013.12.029

URL : http://doi.org/10.1016/j.cell.2013.12.029

B. Ribba, G. Kaloshi, M. Peyre, R. D. Calvez, V. Tod et al., A tumor growth inhibition model for lowgrade glioma treated with chemotherapy or radiotherapy, Clin Cancer Res, vol.15, pp.5071-5080, 2012.
DOI : 10.1158/1078-0432.ccr-12-0084

URL : https://hal.archives-ouvertes.fr/hal-00744626

V. Pérez-garcía, M. Bogdanska, A. Martínez-gonzález, J. Belmonte-beitia, P. Schucht et al., Delay effects in the response of low-grade gliomas to radiotherapy: a mathematical model and its therapeutical implications, Mathematical Medicine and Biology, vol.32, issue.3, pp.307-329, 2015.
DOI : 10.1093/imammb/dqu009

T. Galochkina, A. Bratus, and V. Pérez-garcía, Optimal radiation fractionation for low-grade gliomas: Insights from a mathematical model, Mathematical Biosciences, vol.267, pp.1-9, 2015.
DOI : 10.1016/j.mbs.2015.05.006

V. Pérez-garcía and L. Pérez-romasanta, Extreme protraction for low-grade gliomas: theoretical proof of concept of a novel therapeutical strategy, Mathematical Medicine and Biology, vol.33, issue.3, pp.253-271, 2016.
DOI : 10.1093/imammb/dqv017

M. Badoual, C. Gerin, C. Derouler, B. Grammaticos, J. Llitjos et al., Oedema-based model for diffuse low-grade gliomas: application to clinical cases under radiotherapy, Cell Proliferation, vol.625, issue.4, pp.369-80, 2014.
DOI : 10.1111/cpr.12114

J. Pallud, L. Taillandier, L. Capelle, D. Fontaine, M. Peyre et al., Quantitative Morphological Magnetic Resonance Imaging Follow-up of Low-Grade Glioma, Neurosurgery, vol.71, issue.3, pp.729-740, 2012.
DOI : 10.1227/NEU.0b013e31826213de

D. Louis, H. Ohgaki, O. Wiestler, W. Cavenee, P. Burger et al., World Health Organization classification of tumours of the Central Nervous System, 2007.

R. Soffieti, B. Baumert, L. Bello, A. Von-deimling, H. Duffau et al., Guidelines on management of low-grade gliomas: report of an EFNS-EANO* Task Force, European Journal of Neurology, vol.27, issue.9, pp.1124-1133, 2010.
DOI : 10.1111/j.1468-1331.2010.03151.x

D. Brat and T. Mapstone, Malignant Glioma Physiology: Cellular Response to Hypoxia and Its Role in Tumor Progression, Annals of Internal Medicine, vol.138, issue.8, pp.659-668, 2003.
DOI : 10.7326/0003-4819-138-8-200304150-00014

R. Bristow and R. Hill, Hypoxia and metabolism: Hypoxia, DNA repair and genetic instability, Nature Reviews Cancer, vol.117, issue.3, pp.180-192, 2008.
DOI : 10.1038/nrc2344

P. Kucharzewska, H. Christianson, and M. Belting, Global Profiling of Metabolic Adaptation to Hypoxic Stress in Human Glioblastoma Cells, PLOS ONE, vol.72, issue.1, p.25633823, 2015.
DOI : 10.1371/journal.pone.0116740.s007

M. Chaudhary, S. Bajaj, S. Bohra, N. Swastik, and A. Hande, The domino effect: Role of hypoxia in malignant transformation of oral submucous fibrosis, J Oral maxillofac Pathol, vol.19, issue.2, pp.122-129, 2015.

M. Ruge, T. Simon, B. Suchorska, R. Lehrke, C. Hamisch et al., Stereotactic Brachytherapy With Iodine-125 Seeds for the Treatment of Inoperable Low-Grade Gliomas in Children: Long-Term Outcome, Journal of Clinical Oncology, vol.29, issue.31, pp.4151-4159, 2011.
DOI : 10.1200/JCO.2011.37.3381

M. Ruge, P. Kickingereder, S. Grau, F. Dorn, N. Galldiks et al., Stereotactic iodine-125 brachytherapy for the treatment of WHO grades II and III gliomas located in the central sulcus region, Neuro-Oncology, vol.15, issue.12, pp.1721-1731, 2013.
DOI : 10.1093/neuonc/not126

B. Suchorska, M. Ruge, H. Treuer, V. Sturm, and J. Voges, Stereotactic brachytherapy of low-grade cerebral glioma after tumor resection, Neuro-Oncology, vol.13, issue.10, pp.1133-1142, 2011.
DOI : 10.1093/neuonc/nor100

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3177661

R. Korinthenberg, D. Neuburger, M. Trippel, C. Ostertag, and G. Nikkhah, Long-Term Results of Brachytherapy With Temporary Iodine-125 Seeds in Children With Low-Grade Gliomas, International Journal of Radiation Oncology*Biology*Physics, vol.79, issue.4, pp.1131-1138, 2011.
DOI : 10.1016/j.ijrobp.2009.12.040

S. Gururangan, J. Fangusaro, T. Poussaint, R. Mclendon, A. Onar-thomas et al., Efficacy of bevacizumab plus irinotecan in children with recurrent low-grade gliomas???a Pediatric Brain Tumor Consortium study, Neuro-Oncology, vol.16, issue.2, pp.310-317, 2014.
DOI : 10.1093/neuonc/not154

M. Bogdanska, M. Bodnar, J. Belmonte-beitia, M. Murek, P. Schucht et al., A??mathematical model of low grade gliomas treated with temozolomide and its therapeutical implications, Mathematical Biosciences, vol.288, pp.1-13, 2017.
DOI : 10.1016/j.mbs.2017.02.003

M. Heng, L. Padovani, P. Dory-lautrec, J. Gentet, A. Verschuur et al., Can metronomic maintenance with weekly vinblastine prevent early relapse/progression after bevacizumab-irinotecan in children with low-grade glioma? Cancer Med, pp.1542-1545, 2016.
DOI : 10.1002/cam4.699

URL : http://doi.org/10.1002/cam4.699